In presenting FY22 results PRN highlights the beginnings of a U-shaped recovery. We see an extension of the better 2H22 performance and delivery against guidance of 5-15% EBIT(A) growth in FY23. We believe shareholders will benefit over the medium-term from a focus on earnings quality, capital management, and free cash flow. Maintain BUY.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.